Call for Paper - Upcoming Issues

Prevalence of Asymptomatic Bacteriuria in Children with Sickle Cell Disease

International Journal of Medical Science
© 2024 by SSRG - IJMS Journal
Volume 11 Issue 1
Year of Publication : 2024
Authors : Ali Nassif, Abdulmoneim Ghanem, Maha Khori, Ahmad Chreitah
10.14445/23939117/IJMS-V11I1P101
pdf
How to Cite?

Ali Nassif, Abdulmoneim Ghanem, Maha Khori, Ahmad Chreitah, "Prevalence of Asymptomatic Bacteriuria in Children with Sickle Cell Disease," SSRG International Journal of Medical Science, vol. 11,  no. 1, pp. 1-4, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I1P101

Abstract:

Background: Asymptomatic bacteriuria (ASB) is a common finding in pediatric patients including children with sickle cell (SCD); those children have a great risk of symptomatic urinary tract infections and associated serious Sequelae. Materials and Methods: An observational descriptive study (cross-sectional) was conducted for a period of one year (May 2022 to May 2023) at Tishreen University Hospital in Lattakia-Syria. The study included a group of children with sickle cell anemia who underwent a screening for bacteriuria. Results: A total of 95 children, of which 66.3% were male, and 33.7% were female, with a mean age of 6.7±3.1 years, were enrolled. The prevalence of ASB was 6.3%, and Escherichia coli (E.coli) was the most dominant germ (50%), followed by proteus, staphylococcus aureus, and klebsielleae on average 16.7% of each of them without the presence of significant difference (p>0.05). There was no significant correlation between age (p: 0.1), sex (p: 0.9), and occurrence of ASB. Conclusion: Asymptomatic bacteriuria is a prevalent condition in children with sickle cell anemia without any significant association with demographic characteristics, including age and sex.

Keywords:

Asymptomatic bacteriuria, Children, Prevalence of sickle cell anemia, Syria.

References:

[1] Frederic B. Piel, Martin H. Steinberg, and David C. Rees, “Sickle Cell Disease,” The New England Journal of Medicine, vol. 376, no. 16, pp. 1561–1573, 2017.
[Google Scholar] [Publisher Link]
[2] Lydia H. Pecker, and Sophie Lanzkron, “Sickle Cell Disease,” Annals of Internal Medicine, vol. 174, no. 1, pp. 1-16, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Genes and Disease, Anemia, Sickle Cell, National Library of Medicine, National Center for Biotechnology Information. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK22238/
[4] Vimal K. Derebail et al., “High Prevalence of Sickle Cell Trait in African Americans with ESRD,” Journal of the American Society of Nephrology, vol. 21, no. 3, pp. 413-417, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Sickle Cell Disease, Data & Statistics on Sickle Cell Disease, Centers for Disease Control and Prevention. [Online]. Available: http://www.cdc.gov/ncbddd/sicklecell/data.html/
[6] Prithu Sundd, Mark T. Gladwin, and Enrico M. Novelli, “Pathophysiology of Sickle Cell Disease,” Annual Review of Pathology: Mechanisms of Disease, vol. 14, pp. 263-292, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Donna A. Yosmanovich et al., “Calibrating Sickle Cell Disease,” Journal of Molecular Biology, vol. 428, no. 8, pp. 1506-1514, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Rachel A. Smith et al., “Large Red Cell-Derived Membrane Particles are Major Contributors to Hypercoagulability in Sickle Cell Disease,” Scientific Reports, vol. 11, no. 1, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Gregory J. Kato, Martin H. Steinberg, and Mark T. Gladwin, “Intravascular Hemolysis and the Pathophysiology of Sickle Cell Disease,” The Journal of Clinical Investigation, vol. 127, no. 3, pp. 750-760, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[10] Martin H. Steinberg, and Paolo Sebastiani, “Genetic Modifiers of Sickle Cell Disease,” American Journal of Hematology, vol. 87, no. 8, pp. 795- 803, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Rachel Millner, and Brian Becknell, “Urinary Tract Infection,” Pediatric Clinics of North America, vol. 66, no. 1, pp. 1-13, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Giovanni Montini, Kjell Tullus, and Ian Hewitt, “Febrile Urinary Tract Infections in Children,” The New England Journal of Medicine, vol. 365, no. 3, pp. 239-250, 2011.
[Google Scholar] [Publisher Link]
[13] M. Okarska-Napierala, A. Wasilewska, and E. Kuchar, “Urinary Tract Infection in Children: Diagnosis, Treatment, Imaging-Comparison of Current Guidelines,” Journal of Pediatric Urology, vol. 13, no. 6, pp. 567-573, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Anastasie Nicole Alima Yanda et al., “Burden and Spectrum of Bacterial Infections among Sickle Cell Disease Children Living in Cameroon,” BMC Infectious Diseases, vol. 17, no.211, pp. 1-7, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Erick S. Donkor et al., “Risk of Asymptomatic Bacteriuria among People with Sickle Cell Disease in Accra, Ghana,” Diseases, vol. 5, no. 1, pp. 1-8, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Cypriano Petrus Monaco Junior, Patricia Belintani Blum Fonseca, and Josefina Aparecida Pellegrini Braga, “Infectious Complications after Surgical Splenectomy in Children with Sickle Cell Anemia Disease,” Paulista Journal of Pediatrics, vol. 33, no. 2, pp. 150–153, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Junaid Ansari, and Felicity N.E. Gavins, “Ischemia-Reperfusion Injury in Sickle Cell Disease: from Basics to Therapeutics,” The American Journal of Pathology, vol. 189, no. 4, pp. 706–718, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Jason R Dunkelberger, and Wen-choa Song, “Complement and its Role in Innate and Adaptive Immune Responses,” Cell Research, vol. 20, pp. 34-50, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Paul U. Cameron et al., “Splenectomy Associated Changes in IgM Memory B Cells in an Adult Spleen Registry Cohort,” PLOS ONE, vol. 6, no.8, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Jacqueline M. Hibbert et al., “Erythropoiesis and Myocardial Energy Requirements Contribute to the Hypermetabolism of Childhood Sickle Cell Anemia,” Journal of Pediatric Gastroenterology and Nutrition, vol. 43, pp. 680–687, 2006.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Karl A. Nath, and Robert P. Hebbel, “Sickle Cell Disease: Renal Manifestations and Mechanisms,” Nature Reviews Nephrology, vol. 11, pp. 161- 171, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Bartholomew F Chukwu, Henrietta U Okafor, and Anthony N Ikefuna, “Asymptomatic Bacteriuria in Children with Sickle Cell Anemia at University of Nigeria Teaching Hospital, Enugu, South East, Nigeria,” Italian Journal of Pediatrics, vol. 37, no. 45, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[23] S.A. Adegoke, and P.T. Adegun, “Asymptomatic Bacteriuria in Nigerian Children with Sickle Cell Anemia,” Indian Journal of Nephrology, vol. 23, no. 2, pp. 103-107, 2013.
[Google Scholar] [Publisher Link]
[24] Taonga Musonda et al., “Leukocytosis and Asymptomatic Urinary Tract Infections in Sickle Cell Patients at a Tertiary Hospital in Zambia,” Anemia, vol. 2020, pp. 1-5, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[25] Nouran Osama Abdel Kader et al., “Screening of Asymptomatic Bacteriuria in Sickle Cell Pediatric Patients,” QJM: An International Journal of Medicine, vol. 114, no. 1, 2021.
[CrossRef] [Google Scholar] [Publisher Link]